bismuth has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral-Romero, C; Chellam, S; García-Cuellar, CM; Hernández-Delgadillo, R; Meester, I; Nakagoshi-Cepeda, MAA; Nakagoshi-Cepeda, SE; Pineda-Aguilar, N; Sánchez-Nájera, RI; Sánchez-Pérez, Y; Solis-Soto, JM | 1 |
| Allen, KJH; Dadachova, E; Jiao, R; Malo, ME; Rickles, D | 1 |
| Parks, NJ; Pikul, SS; Schneider, PD | 1 |
3 other study(ies) available for bismuth and B16 Melanoma
| Article | Year |
|---|---|
Bismuth Lipophilic Nanoparticles (BisBAL NP) Inhibit the Growth of Tumor Cells in a Mouse Melanoma Model.
Topics: Animals; Antineoplastic Agents; Bismuth; Cell Line, Tumor; Dimercaprol; Humans; Melanoma, Experimental; Mice; Nanoparticles; Organometallic Compounds | 2022 |
Evaluating the Combination of Radioimmunotherapy and Immunotherapy in a Melanoma Mouse Model.
Topics: Animals; Antineoplastic Agents, Immunological; Bismuth; Cell Line, Tumor; Female; Male; Melanoma, Experimental; Mice; Programmed Cell Death 1 Receptor; Radioimmunotherapy; Radioisotopes | 2020 |
In vitro killing of melanoma by liposome-delivered intracellular irradiation.
Topics: Alpha Particles; Animals; Bismuth; Brachytherapy; Cell Survival; Dose-Response Relationship, Radiation; Half-Life; Lead Radioisotopes; Liposomes; Melanoma, Experimental; Mice; Pharmaceutical Vehicles; Radioisotopes; Time Factors; Tumor Cells, Cultured | 1987 |